AI 활용 진단 방사선유전체학 디바이스 시장 보고서(2026년)

Artificial intelligence-powered diagnostic radiogenomics devices are advanced medical systems that combine imaging data with genomic and molecular profiles using artificial intelligence algorithms to detect correlations between radiographic characteristics and underlying genetic expressions, allowing for more accurate disease characterization, risk assessment, and prediction of treatment responses at an individual patient level. These devices are applied in both clinical and research environments to improve early detection, support personalized treatment planning, enhance prognostic evaluation, and enable the advancement of precision medicine approaches by integrating radiology and genomics data analytics.

The primary components of artificial intelligence (AI)-powered diagnostic radiogenomics devices include hardware, software, and services. Hardware comprises the physical imaging equipment and computational infrastructure used to acquire, analyze, and process medical imaging data for radiogenomic evaluation. These devices operate across multiple imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, X-ray or mammography, and multi-modal fusion technologies. Their key applications span oncology, neurology, cardiology, and infectious disease diagnostics. These solutions are widely adopted by hospitals and clinics, diagnostic imaging centers, academic and research institutions, biobanks, pharmaceutical and biotechnology companies, contract research organizations, as well as government and public health programs.

Tariffs are influencing the artificial intelligence (AI)-powered diagnostic radiogenomics devices market by increasing the cost of imported imaging sensors, semiconductor components, computational processing units, and genomic data analysis systems required for advanced diagnostic platforms. This is impacting manufacturing costs and slowing the deployment of precision diagnostic technologies, particularly in regions dependent on imported healthcare and imaging equipment such as Asia-Pacific and Europe. Segments including magnetic resonance imaging systems, artificial intelligence diagnostic algorithms, and radiogenomic analysis software are most affected due to global supply chain dependencies and rising equipment expenses. However, tariffs are also encouraging regional manufacturing expansion, local software development, and investments in domestic healthcare technology ecosystems, thereby creating long-term resilience and innovation opportunities within the market.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered diagnostic radiogenomics devices market statistics, including artificial intelligence (AI)-powered diagnostic radiogenomics devices industry global market size, regional shares, competitors with a artificial intelligence (AI)-powered diagnostic radiogenomics devices market share, detailed artificial intelligence (AI)-powered diagnostic radiogenomics devices market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered diagnostic radiogenomics devices industry. This artificial intelligence (AI)-powered diagnostic radiogenomics devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market size has grown rapidly in recent years. It will grow from $0.62 billion in 2025 to $0.74 billion in 2026 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to growing prevalence of chronic and complex diseases, rising adoption of advanced diagnostic imaging technologies, increasing investment in precision medicine research initiatives, expansion of genomic sequencing and molecular profiling applications, growing demand for data-driven clinical decision-making solutions.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market size is expected to see rapid growth in the next few years. It will grow to $1.5 billion by 2030 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to increasing demand for AI-enabled personalized treatment planning solutions, rising adoption of cloud-based radiogenomic data analytics platforms, growing integration of genomics with diagnostic imaging workflows, increasing investment in oncology and neurology precision diagnostics, rising focus on early disease detection and predictive healthcare technologies. Major trends in the forecast period include increasing adoption of multimodal imaging and genomics integration platforms, growing demand for personalized and precision diagnostic solutions, rising use of predictive analytics for disease prognosis and therapy response assessment, increasing implementation of automated radiogenomic data interpretation tools, growing focus on real-time clinical decision support in diagnostic workflows.

The increasing adoption of precision medicine approaches is expected to propel the growth of the AI-powered diagnostic radiogenomics devices market going forward. Precision medicine approaches refer to medical strategies that tailor disease prevention, diagnosis, and treatment based on individual genetic, environmental, and lifestyle variations. The rising adoption of precision medicine is primarily driven by the expanding integration of genomic data into clinical decision-making processes across advanced healthcare systems. AI-powered diagnostic radiogenomics devices support this trend by combining medical imaging data with genomic datasets to enable precise disease profiling, early diagnosis, and personalized treatment planning. For instance, in February 2024, according to a report by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, more than one-third of new drug approvals by the U. S. Food and Drug Administration were personalized therapies for four consecutive years through 2023. Therefore, the increasing adoption of precision medicine approaches is contributing to and supporting the growth of the AI-powered diagnostic radiogenomics devices market.

Leading companies operating in the AI-powered diagnostic radiogenomics devices market are increasingly focusing on technological advancements such as imaging quality assessment tools to enhance diagnostic accuracy and standardization. An imaging quality assessment tool is a software-based system that uses advanced algorithms to evaluate, standardize, and ensure the reliability of medical imaging data. For example, in June 2025, Quibim, a Spain-based medical imaging technology company, launched AI-QUAL, a solution that applies artificial intelligence to automatically assess prostate magnetic resonance imaging quality, assign standardized scores, and detect artifacts that may compromise diagnostic outcomes. The tool enhances radiology workflows and supports more reliable clinical decision-making by ensuring high-quality imaging data, which is essential for downstream applications such as radiogenomics.

In March 2026, RadNet acquired Gleamer for $270 million. The acquisition is intended to strengthen RadNet's artificial intelligence capabilities in radiology by incorporating Gleamer's diagnostic technologies and global software-as-a-service platform across X-ray, mammography, CT, and MRI imaging. This integration is expected to improve imaging workflows related to screening, detection, and diagnostic interpretation for conditions including cancer, musculoskeletal disorders, and neurodegenerative diseases.

Major companies operating in the artificial intelligence (ai)-powered diagnostic radiogenomics devices market are Thermo Fisher Scientific Inc., Siemens Healthineers AG, Philips Healthcare (Koninklijke Philips N. V. ), GE HealthCare Technologies Inc., Agilent Technologies Inc., Canon Medical Systems Corporation, Tempus AI Inc., Aidoc Medical Ltd., Owkin Inc., SOPHiA GENETICS SA, Lunit Inc., Synaptive Medical Inc., Median Technologies SA, Perspectum Ltd., Quibim S. L., Seno Medical Instruments Inc., Ultromics Limited, QMENTA Inc., Imbio LLC, Mirada Medical Limited, VUNO Inc., Radiomics. bio Inc., Qlucore AB, CureMetrix Inc.

North America was the largest region in the artificial intelligence (AI)-powered diagnostic radiogenomics devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered diagnostic radiogenomics devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-powered diagnostic radiogenomics devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market consists of sales of radiogenomic data integration platforms, artificial intelligence-based image-genomic correlation software, predictive analytics engines for genotype-phenotype mapping, cloud-enabled radiogenomics processing systems,, genomic annotation and imaging biomarker extraction tools, and interoperable radiology-genomics data management systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai)-powered diagnostic radiogenomics devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-powered diagnostic radiogenomics devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered diagnostic radiogenomics devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Imaging Modality: Magnetic Resonance Imaging; Computed Tomography; Positron Emission Tomography; Ultrasound; X-Ray Or Mammography; Multi-Modal Fusion
• 3) By Application: Oncology; Neurology; Cardiology; Infectious Diseases
• 4) By End User: Hospitals And Clinics; Diagnostic Imaging Centers; Academic And Research Institutes And Biobanks; Pharmaceutical And Biotechnology Companies And Contract Research Organizations; Government And Public Health Programs
• Subsegments:
• 1) By Hardware: Imaging Sensors; Computational Processing Units; Data Storage Systems; Networking And Connectivity Modules; User Interface Devices
• 2) By Software: Radiogenomic Analysis Software; Artificial Intelligence Diagnostic Algorithms; Image Processing And Enhancement Software; Data Visualization And Reporting Tools; Machine Learning Model Management Software
• 3) By Services: Installation And Setup Services; Calibration And Maintenance Services; Training And Support Services; Data Management And Integration Services; Clinical Workflow Optimization Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Siemens Healthineers AG; Philips Healthcare (Koninklijke Philips N.V.); GE HealthCare Technologies Inc.; Agilent Technologies Inc.; Canon Medical Systems Corporation; Tempus AI Inc.; Aidoc Medical Ltd.; Owkin Inc.; SOPHiA GENETICS SA; Lunit Inc.; Synaptive Medical Inc.; Median Technologies SA; Perspectum Ltd.; Quibim S.L.; Seno Medical Instruments Inc.; Ultromics Limited; QMENTA Inc.; Imbio LLC; Mirada Medical Limited; VUNO Inc.; Radiomics.bio Inc.; Qlucore AB; CureMetrix Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Multimodal Imaging And Genomics Integration Platforms
  • 4.2.2 Growing Demand For Personalized And Precision Diagnostic Solutions
  • 4.2.3 Rising Use Of Predictive Analytics For Disease Prognosis And Therapy Response Assessment
  • 4.2.4 Increasing Implementation Of Automated Radiogenomic Data Interpretation Tools
  • 4.2.5 Growing Focus On Real-Time Clinical Decision Support In Diagnostic Workflows

5. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Diagnostic Imaging Centers
• 5.3 Academic And Research Institutes And Biobanks
• 5.4 Pharmaceutical And Biotechnology Companies And Contract Research Organizations
• 5.5 Other End Users

6. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Segmentation

• 9.1. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hardware, Software, Services
• 9.2. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Ultrasound, X-Ray Or Mammography, Multi-Modal Fusion
• 9.3. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Neurology, Cardiology, Infectious Diseases
• 9.4. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Diagnostic Imaging Centers, Academic And Research Institutes And Biobanks, Pharmaceutical And Biotechnology Companies And Contract Research Organizations, Government And Public Health Programs
• 9.5. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Imaging Sensors, Computational Processing Units, Data Storage Systems, Networking And Connectivity Modules, User Interface Devices
• 9.6. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Radiogenomic Analysis Software, Artificial Intelligence Diagnostic Algorithms, Image Processing And Enhancement Software, Data Visualization And Reporting Tools, Machine Learning Model Management Software
• 9.7. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Installation And Setup Services, Calibration And Maintenance Services, Training And Support Services, Data Management And Integration Services, Clinical Workflow Optimization Services

10. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Regional And Country Analysis

• 10.1. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 11.1. Asia-Pacific Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 12.1. China Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 13.1. India Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 14.1. Japan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 15.1. Australia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 16.1. Indonesia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 17.1. South Korea Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 18.1. Taiwan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 19.1. South East Asia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 20.1. Western Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 21.1. UK Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 22.1. Germany Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 23.1. France Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 24.1. Italy Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 25.1. Spain Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 26.1. Eastern Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 27.1. Russia Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 28.1. North America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 29.1. USA Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 30.1. Canada Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 31.1. South America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 32.1. Brazil Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 33.1. Middle East Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

• 34.1. Africa Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market, Segmentation By Component, Segmentation By Imaging Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Competitive Landscape And Company Profiles

• 36.1. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Philips Healthcare (Koninklijke Philips N.V.) Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Other Major And Innovative Companies

• Canon Medical Systems Corporation, Tempus AI Inc., Aidoc Medical Ltd., Owkin Inc., SOPHiA GENETICS SA, Lunit Inc., Synaptive Medical Inc., Median Technologies SA, Perspectum Ltd., Quibim S.L., Seno Medical Instruments Inc., Ultromics Limited, QMENTA Inc., Imbio LLC, Mirada Medical Limited

38. Global Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market

41. Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market High Potential Countries, Segments and Strategies

• 41.1 Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer